Development and validation of LC-MS/MS method for quantification of bisphenol A and estrogens in human plasma and seminal fluid
Language English Country Netherlands Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't, Validation Study
PubMed
26048824
DOI
10.1016/j.talanta.2015.03.013
PII: S0039-9140(15)00166-6
Knihovny.cz E-resources
- Keywords
- Bisphenol A, Estradiol, Estriol, Estrone, LC–MS, Semen,
- MeSH
- Benzhydryl Compounds analysis blood MeSH
- Chromatography, Liquid methods MeSH
- Endocrine Disruptors analysis blood MeSH
- Estrogens analysis blood MeSH
- Estrone analysis blood MeSH
- Phenols analysis blood MeSH
- Humans MeSH
- Limit of Detection MeSH
- Semen chemistry MeSH
- Tandem Mass Spectrometry methods MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Validation Study MeSH
- Names of Substances
- Benzhydryl Compounds MeSH
- bisphenol A MeSH Browser
- Endocrine Disruptors MeSH
- Estrogens MeSH
- Estrone MeSH
- Phenols MeSH
Bisphenol A (BPA) is a widely known endocrine disruptor with estrogenic, antiestrogenic or antiandrogenic properties. BPA could interfere with estrogen metabolism as well with receptor-mediated estrogen actions. Both environmental BPA and estrogens may be traced in body fluids, of which, besides the blood plasma, the seminal fluid is of particular interest regarding their possible interactions in the testis. The method for simultaneously determining BPA and estrogens is then needed, taking into account that their concentrations in these body fluid may differ. Here the method was developed and validated for measurements of BPA, estrone (E1), estradiol (E2) and estriol (E3) in blood plasma and seminal plasma using liquid chromatography-tandem mass spectrometry. Due to the phenolic moiety of all compounds, dansyl chloride derivatization could be used. The analytical criteria of the method with respect to expected concentration of the analytes were satisfactory. The lower limits of quantifications (LLOQ) amounted to 43.5, 4.0, 12.7, 6.7 pg/mL for plasma BPA, E1, E2 and E3, and 28.9, 4.9, 4.5, 3.4 pg/mL for seminal BPA, E1, E2 and E3, respectively. The concentrations of individual steroids differed between body fluids. To the best of our knowledge, this is the first method that enabled the measurement of estrogens and BPA together in one run. The concentrations of E1, E2 and for the first time also of E3 in seminal plasma in normospermic men are reported.
References provided by Crossref.org
The Role of 11-Oxygenated Androgens and Endocrine Disruptors in Androgen Excess Disorders in Women
COVID-19, Vaccination, and Female Fertility in the Czech Republic
Determination of bisphenol A in commercial cat food marketed in the Czech Republic
Release of Bisphenol A from Milled and 3D-Printed Dental Polycarbonate Materials
Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?
Dental composites - a low-dose source of bisphenol A?
Steroid diagnostics of 21st century in the light of their new roles and analytical tools
Occurrence and reproductive roles of hormones in seminal plasma